Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations

Launched by H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE · Jan 6, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring how obesity may affect the development of pancreatic cancer, particularly in minority groups. Researchers want to understand the specific ways that being overweight might lead to this type of cancer. The study is currently looking for participants, specifically adults aged 18 and older who identify as African American or Non-Hispanic White, and who have been referred to certain medical centers in Florida or Mississippi because there is a concern about pancreatic tumors.

If you or a loved one are eligible and decide to participate, you will be part of a team trying to uncover important information about pancreatic cancer and obesity. Participants can expect to undergo assessments and provide information that may help improve understanding and treatment of pancreatic cancer in the future. It's important to note that individuals under 18 years old or those with no suspicion or diagnosis of a pancreatic tumor cannot take part in this study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults 18 years of age or older at time of signing informed consent
• • Patients who self-report as African American, Non-Hispanic White
• • Patients who present to the gastrointestinal (GI) clinic, surgery, or endoscopy at a participating Florida Pancreas Collaborative (FPC) site or the University of Mississippi Medical Center (UMMC) with a clinical suspicion or diagnosis of a pancreatic tumor.
• Exclusion Criteria:
• • Patient under 18 years of age
• • Has no suspicion or diagnosis of a pancreatic cancer or tumor
• • Self-reported race/ethnicity other than African American or Non-Hispanic White.